Intestinal Infarction (Mesenteric Infarction): Drug Therapy

Therapeutic target

• Avoidance of complications

Therapy recommendations

• Intensive medical therapy (ensuring vital functions):
  • Intravascular (“into” a vessel) fluid substitution to stabilize hemodynamics (blood flow).
  • Anticoagulation (inhibition of blood clotting) with heparin to prevent exacerbation (“worsening”) of thromboembolic occlusive processes
  • Antibiotic therapy
  • In non-occlusive mesenteric ischemia (NOD; ischemia (reduced supply) due to cardiovascular disturbances (e.g., due to a drop in cardiac output, HRV) with reactive vasospasm in the mesenteric stromal area (area of the vessels supplying the intestine)): Prostaglandins and heparin (anticoagulation).
• See also under “Surgical therapy” and “Other therapy”.